| 书目名称 | Hematopoietic Growth Factors in Oncology | | 副标题 | Basic Science and Cl | | 编辑 | George Morstyn,MaryAnn Foote,Graham J. Lieschke | | 视频video | | | 概述 | Includes supplementary material: | | 丛书名称 | Cancer Drug Discovery and Development | | 图书封面 |  | | 描述 | Whether to promote platelet recovery or to ameliorate the complications of cancer and the side effects of chemotherapy, hematopoietic growth factors (HGFs) now account for more than $5 billion per year of the US health care budget. In Hematopoietic Growth Factors in Oncology: Basic Science and Clinical Therapeutics, leading oncologists, hematologists, and nephrologists comprehensively review the role of HGFs in clinical practice, explain the molecular basis of their effects, and consider potential future developments. The authors focus on the use of HGFs in oncology, describing their cutting-edge application to patients with lung cancer, Hodgkin‘s and non-Hodgkin‘s lymphoma, breast cancer, chronic lymphocytic leukemia, AIDS-related malignancies, myelodysplastic syndromes, and aplastic anemias. Among the HGFs described are granulocyte colony-stimulating factor, erythropoietc factors, thrombopoietic factors, and stem-cell factor and its receptor, c-kit. To complete their survey, the contributors also consider the safety and economic implications of HGFs and the future potential for HGF antagonists in oncology..Comprehensive and up-to-date, Hematopoietic Growth Factors in Oncology: Ba | | 出版日期 | Book 2004 | | 关键词 | anemia; cell; cytokines; leukemia; lymphoma; pathology; pharmacology; stem cell | | 版次 | 1 | | doi | https://doi.org/10.1007/978-1-59259-747-5 | | isbn_softcover | 978-1-4684-9847-9 | | isbn_ebook | 978-1-59259-747-5Series ISSN 2196-9906 Series E-ISSN 2196-9914 | | issn_series | 2196-9906 | | copyright | Springer Science+Business Media New York 2004 |
The information of publication is updating
|
|
发表于 2025-3-21 18:41:58
